Reckitt Benckiser Group (OTCMKTS:RBGLY) Cut to Equal Weight at Morgan Stanley

Reckitt Benckiser Group (OTCMKTS:RBGLYGet Free Report) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research note issued to investors on Monday.

RBGLY has been the subject of several other reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Monday, October 27th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Reckitt Benckiser Group in a report on Thursday, October 23rd. Finally, Barclays upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 1st. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Read Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Down 0.1%

OTCMKTS:RBGLY traded down $0.01 during mid-day trading on Monday, hitting $16.08. 70,371 shares of the company’s stock traded hands, compared to its average volume of 337,964. The company has a fifty day moving average of $15.58 and a 200 day moving average of $14.93. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a twelve month low of $11.73 and a twelve month high of $16.30.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Recommended Stories

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.